Marshall Wace’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,074
Closed -$288K 3039
2025
Q2
$288K Sell
10,074
-10,308
-51% -$277K ﹤0.01% 2338
2025
Q1
$508K Sell
20,382
-109,199
-84% -$2.6M ﹤0.01% 2075
2024
Q4
$2.93M Buy
129,581
+72,740
+128% +$1.58M ﹤0.01% 1295
2024
Q3
$1.21M Buy
56,841
+41,478
+270% +$816K ﹤0.01% 1571
2024
Q2
$293K Buy
15,363
+1,207
+9% +$24.6K ﹤0.01% 2167
2024
Q1
$273K Buy
+14,156
New +$281K ﹤0.01% 2143
2023
Q4
Sell
-150,016
Closed -$3.23M 2308
2023
Q3
$3.23M Buy
+150,016
New +$3.64M 0.01% 1026
2022
Q4
Sell
-311,743
Closed -$4.38M 3092
2022
Q3
$4.38M Buy
311,743
+286,838
+1,152% +$5.42M 0.01% 1463
2022
Q2
$621K Buy
+24,905
New +$744K ﹤0.01% 2689
2022
Q1
Sell
-12,329
Closed -$400K 3552
2021
Q4
$400K Buy
+12,329
New +$406K ﹤0.01% 2913
2021
Q1
Sell
-54,400
Closed -$2.26M 2596
2020
Q4
$2.26M Sell
54,400
-23,717
-30% -$988K 0.01% 902
2020
Q3
$3.32M Buy
+78,117
New +$3.37M 0.02% 658
2020
Q2
Sell
-76,485
Closed -$2.51M 1679
2020
Q1
$2.51M Sell
76,485
-26,791
-26% -$996K 0.03% 554
2019
Q4
$3.8M Buy
103,276
+36,884
+56% +$1.31M 0.03% 621
2019
Q3
$2.23M Buy
66,392
+8,323
+14% +$295K 0.02% 733
2019
Q2
$2.28M Sell
58,069
-101,573
-64% -$4.02M 0.02% 736
2019
Q1
$6.47M Buy
159,642
+58,904
+58% +$2.2M 0.06% 391
2018
Q4
$3.26M Buy
+100,738
New +$4.07M 0.03% 594
2017
Q1
Sell
-33,883
Closed -$1.43M 453
2016
Q4
$1.43M Buy
+33,883
New +$1.38M 0.01% 708
2016
Q3
Sell
-12,560
Closed -$547K 1003
2016
Q2
$547K Sell
12,560
-7,749
-38% -$334K ﹤0.01% 811
2016
Q1
$895K Buy
+20,309
New +$860K 0.01% 739

Other funds holding FMS

Marshall Wace's FMS Position: Q3 2025 in Review

Marshall Wace sold out of Fresenius Medical Care (FMS) in Q3 2025, closing a stake of 10,074 shares — an estimated $288K sold.

Marshall Wace first reported a position in FMS in Q1 2016 and held it in 21 quarters. The position peaked at $6.47M in Q1 2019. 205 funds tracked by Wall St. Rank hold FMS as of Q3 2025.

  • Marshall Wace reported no remaining Fresenius Medical Care position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 10,074 Fresenius Medical Care shares in Q3 2025, an estimated $288K.
  • Marshall Wace first reported a position in Fresenius Medical Care in Q1 2016 and held it in 21 quarters.
  • Marshall Wace's Fresenius Medical Care position peaked at $6.47M in Q1 2019.
  • 205 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.